Group 6 Copy 73
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Why be social? The costs and benefits of sociality in spiders

    Sociality in spiders is extremely rare, but it has evolved several times. This begs the question: why be social...

    Go West, young man: in search of the A00 haplogroup among peoples of Western Cameroon

    Welcome to our citizen-science research project on haplogroup A00 in Cameroon! Having successfully sampled the...

    Backer Badge Funded

    A biology project funded by 47 people